Introduction
Accounting for only 2% of the body mass, yet receiving 20% of the cardiac output, the mammalian brain critically relies on an elaborate vascular network for its oxygen and nutrient supply. Estimations suggest that the human brain contains up to 100 billion vessels, i.e., a vessel for each neuron. The vascular system developed more recently in evolution than the nervous system. In primitive organisms such as C. elegans, the need for motor coordination triggered development of a nervous system, but since oxygen diffuses to all cells in these small species, there was no need to develop an elaborate vasculature. Only later in evolution, when organisms became larger and (metabolically) more active, a more efficient system for oxygen transportation was required. Hence, in vertebrates, a highly branched vasculature lined by an endothelium developed to nourish organs including the central nervous system (CNS) and peripheral nervous system (PNS).
A key ancestral function of vessels is to supply oxygen and nutrients. Hence, shortage of oxygen is a key stimulus to vascularize the developing CNS. However, the role of vessels in the CNS extends beyond merely supplying nutrients. Indeed, by releasing ''angiocrine'' factors, endothelial cells (ECs) not only produce instructive signals for neural development, but also support normal functioning, ensure maintenance, and promote reparative regeneration of the CNS (Butler et al., 2010) . Moreover, to maintain neuronal homeostasis, brain vessels have a blood-brain barrier (BBB), comprising ECs, pericytes (e.g., mural cells of the vascular smooth muscle lineage surrounding capillaries), astrocytic endfeet, and neurons (Zlokovic, 2008) . This ''neurovascular unit'' is only one of the examples of the intertwined connection between the neural and vascular system.
Elucidating the crosstalk between both systems is important, not only to better understand the molecular and cellular basis of how the nervous system operates, but also to develop novel therapeutic strategies for neurological disorders. In this review, we will discuss key principles and molecules governing development and function of the CNS vasculature, focusing on recent discoveries with a translational potential, rather than providing an encyclopedic survey. For reasons of brevity, we will discuss the neurovascular link in the PNS only briefly.
Vessel Development in the CNS

Model of Vessel Branching
Initial vascularization of the embryonic CNS relies on ''vasculogenesis,'' when angioblasts from the paraxial mesoderm coalesce to form a primitive network around the neural tube in the so-called perineural vascular plexus (PNVP). Via inward sprouting, new vessel branches invade the neural tube, a process termed ''angiogenesis,'' to establish the intraparenchymal vascular network.
Vascular development is a complex process, orchestrated by an interplay of numerous molecules (Carmeliet and Jain, 2011a) . Several of them regulate angiogenesis in multiple organs and thus act as ''general'' angiogenic factors, but emerging evidence indicates that organs establish their own vascular bed in a specific pattern, adapted to meet local metabolic and functional needs. Here, we will limit our discussion to some of the key general angiogenic agents, implicated in a recently postulated vessel branching model (Carmeliet and Jain, 2011a) , and thereafter discuss a few examples of brain-specific angiogenic factors.
Vessel branching relies on a coordinated collective migration of ECs, in which one particular cell, the ''tip cell,'' takes the lead to guide the following ''stalk cells'' that elongate the sprout (Carmeliet and Jain, 2011a) . This tip cell is exposed to the highest levels of VEGF, released by hypoxic neural tissue ( Figure 1A ). Signaling by the VEGF receptor VEGFR2 instructs this tip cell to extend numerous filopodia that explore the environment and guide the branch toward the source of proangiogenic factors. VEGF signaling in the tip cell induces expression of Dll4, which activates the Notch1 receptor on neighboring ECs to prevent tip cell induction and thereby induce a stalk cell identity (Figure 1B) . Stalk cells proliferate, elongate the stalk, and form a lumen. Once new vessel branches fuse and become perfused, ECs resume quiescence and form a monolayer of ''phalanx cells'' with a streamlined surface to conduct flow; these cells have oxygen sensors to readjust endothelial morphogenesis to improve oxygen supply (Carmeliet and Jain, 2011b) . Other angiogenic pathways have been implicated in tip cell guidance and outgrowth, stalk cell elongation, and phalanx cell stabilization, even though their precise role in brain vascularization has not always been characterized (Carmeliet and Jain, 2011a) .
Selective Mechanisms of Brain Vascularization
Some angiogenic pathways play a more important role in the vascularization of the developing CNS than of peripheral organs. Periventricular vessel growth in the telencephalon progresses in a ventral-to-dorsal gradient, established by compartmentspecific homeobox transcription factors in ECs (Dlx1/2, Nkx2.1, and Pax6) (Vasudevan et al., 2008) . Though it is unclear how these factors regulate EC responses, these findings challenge the dogma that vessels sprout only in response to angiogenic signals, locally produced by hypoxic brain cells.
Another pathway implicated in the formation of the CNS vasculature is Wnt/b-catenin signaling (Daneman et al., 2009; Liebner et al., 2008; Stenman et al., 2008) . The neuroepithelium secretes Wnt ligands that bind to the Frizzled (Fzd)/Lrp5/6 receptor complex on ECs, leading to stabilization of b-catenin and transcription of downstream targets ( Figure 1B ). Combined loss of Wnt7a and Wnt7b impairs vascular integrity and invasion in the neuroectoderm (Dejana, 2010) . Wnt promotes BBB differentiation of brain ECs, stimulates proliferation of stalk cells, and promotes stability of new vascular connections (Phng et al., 2009) . The WNT cascade intertwines with other angiogenic pathways including VEGFR2 and Notch1 signaling, which enhance b-catenin's activity (Phng et al., 2009) ; Wnt signaling also upregulates Notch1 in a feedback loop ( Figure 1B ). In line with findings that mutations in the human Fzd4 receptor or Lrp5 coreceptor cause retinal hypovascularization, endothelial loss of Fzd4 in mice causes vascular defects and disrupts the BBB (Ye et al., 2009) .
Only a few molecules have been implicated in brain-specific vascular development. The orphan G protein-coupled receptor GPR124 regulates vessel sprouting from the PNVP in the forebrain Cullen et al., 2011; Kuhnert et al., 2010) . Signaling via receptor Cxcr4 in response to ligand Cxcl12b controls the formation of arteriovenous connections in the CNS but not in the trunk of zebrafish embryos (Bussmann et al., 2011; Fujita et al., 2011) . During basilar artery formation, venous-derived ECs expressing Cxcr4 are attracted by Cxcl12b, produced by the hindbrain adjacent to the basilar artery. Once this vascular connection is established, hemodynamics downregulate Cxcr4 to silence tip cell behavior and sprouting.
It is noteworthy that signals like Wnt and Cxcl12b (SDF-1a in mice) are not unique for developmental CNS vascularization (they can also signal vessel growth in pathology), but at least during particular developmental windows, they seem to be more selectively involved in CNS vascular development. Other molecules must control brain vascularization-identifying these organ-specific candidates may offer opportunities for selectively targeting brain vessels in brain disease. (B) Signaling events that regulate guidance of the tip cell (green) and proliferation of the stalk cells (purple). VEGF signaling in the tip cell induces upregulation of Dll4, which activates Notch signaling in neighboring stalk cells. Wnts induce b-catenin-mediated transcription of target genes to stimulate stalk cell proliferation and brain EC differentiation. The GPR124 orphan receptor also regulates vessel formation in the CNS.
Origin and Development of Brain Vessels
Once a luminized vessel is formed, maturation of the vessel wall is necessary to ensure a stable network and optimal blood flow. The tightly aligned EC barrier gains stability via coverage of mural cells, i.e., pericytes around capillaries and smooth muscle cells (SMCs) around arterioles that deposit extracellular matrix (ECM) and affect EC functions. In the vertebrate forebrain, ECs derive from cephalic mesoderm, while mural cells arise from ectodermal tissue, i.e., the neural crest and neuroectoderm (Etchevers et al., 2001; Kurz, 2009) . By contrast, pericytes in the posterior brain originate from mesodermal cells, though they can also derive from the bone marrow, at least in the adult. The sharp demarcation of vascular regions in mural cell coverage likely occurred at a critical switch in evolution, when the neural crest contributed to cephalic structures (forebrain, jaws) that offered vertebrates the advantage of higher order coordination and active feeding lifestyle. The role of mural cells extends beyond providing mechanical stability alone, as ECs and mural cells influence each other's proliferation, differentiation, and survival (Carmeliet and Jain, 2011a) . Noteworthy, the segmental appearance of some cerebral vascular malformations (for instance, Sturge-Weber syndrome) has been linked to the metameric origin of neural crest cells and their defined migration patterns into distinct brain regions (Krings et al., 2007) .
Compared to peripheral vessels, cerebral vessels exhibit a number of distinct features. In no other organ, capillary endothelial cells are thinner yet have a tighter barrier, a higher degree of pericyte coverage, and a more intricate communication with the surrounding parenchymal cells. However, the cerebral arteries show a thinner, more fragile wall (thinner adventitia, underdeveloped external elastic lamina) and arborize in a highly branched and bifurcated network, conditions that render them vulnerable to aneurysms and atherosclerosis caused by shear stress (Nixon et al., 2010) . Moreover, region-specific differences determine vulnerability to vascular disease. For instance, compared to the gray matter, the microvascular density is lower in the subcortical white matter and its arteries are coiled as they lack a tight parenchymal support. This, together with the fact that terminal arterioles in this region exhibit limited potential for collateral flow, renders the white matter especially vulnerable to ischemia and hemorrhages due to small vessel disease. Vessel Maturation: Recruitment of Pericytes Pericytes are stellate-shaped cells that ensheath large areas of capillary ECs in an umbrella-like fashion, make peg-socked contacts with ECs, and lie embedded in the EC basement membrane. To recruit pericytes around vessels, ECs secrete PDGF-B binding PDGFRb on pericytes (Gaengel et al., 2009) (Figure 2 ). Furthermore, Notch3 signaling promotes maturation of pericytes, likely in response to the EC-derived Jagged-1 (Liu et al., 2010) . In turn, pericytes secrete angiopoietin-1 (Ang1) that binds to the endothelial Tie2 receptor to promote EC survival, cell-cell adhesion, and pericyte coverage (Augustin et al., 2009) . A recent study challenged the dogma that Ang1 is necessary for pericyte recruitment and coverage of quiescent vessels. They showed that Ang1 acts as a ''brake'' to balance the enhanced angiogenic activity in development or pathology and is necessary to form properly sized and branched vessels (Jeansson et al., 2011) . Finally, mural cell-derived TGFb1 can promote pericyte differentiation and maturation, though this signaling pathway can also stimulate vessel growth in a context-dependent pattern (Pardali et al., 2010) . Additional signals regulate pericyte recruitment and maturation, EC survival and quiescence, and basement membrane deposition (Carmeliet and Jain, 2011a) . Abnormal Vessel Growth in the Absence of Pericytes Mice with mutations in the PDGF-B/PDGFRb pathway form vessels with varying levels of pericyte recruitment; analysis of these lines reveals that pericytes have context-dependent effects on CNS vessel morphogenesis in growing versus quiescent vessels. Embryos carrying PDGFRb mutations form cerebral endothelial-lined channels but recruit fewer pericytes, with the most severely affected vessels becoming enlarged, microaneurysmatic and leaky (Gaengel et al., 2009) . Complete embryonic absence of pericytes results in perinatal death due to edema and hemorrhage from vessels displaying EC hyperplasia and overactivation, indicating that pericytes function to silence EC growth in growing vessels (Gaengel et al., 2009) . Pericyte deficiency can also contribute to (pathological) neovessel growth, not only by unleashing the brake to EC proliferation but also by creating a proangiogenic environment. In adult diabetic retinopathy for instance, pericyte degeneration renders vessels leaky and causes bleeding, which evokes hypoxia, a strong stimulus of angiogenesis.
More modest pericyte deficiency in quiescent vessels in adulthood decreases vessel density (Bell et al., 2010) , likely because insufficient production of pericyte-derived EC survival factors such as Ang1 and VEGF favors vessel pruning (Quaegebeur et al., 2010) . Another explanation is that pericytes control angiogenic sprouting, though the relevance of this process requires further study. In the CNS, pericytes are detected around PDGF-B expressing tip cells, where they affect vascular branching (Liu et al., 2009) . Some studies documented so-called ''pericyte-driven'' angiogenesis, where pericyte sleeves attract ECs via expression of VEGF and the proteoglycan NG2.
Sealing Off the Neurovascular Unit via Matrix Anchorage
The different cellular components of the vascular wall must be tightly sealed to each other and anchored to the perivascular matrix. This requires deposition of a basement membrane, interactions with matrix components, and establishment of cell-cell junctions (Carmeliet and Jain, 2011a) . For instance, by linking the endothelial cytoskeleton to the ECM, the superfamily of integrin surface receptors affects EC proliferation, migration and morphogenesis (Desgrosellier and Cheresh, 2010) . Hence, deficiency of av-integrin causes cerebral bleeding, while loss of SMC integrin b1 results in hemorrhages due to weak EC-pericyte interactions (Abraham et al., 2008) .
Development of the Blood-Brain Barrier CNS vessels establish a BBB to secure neuronal homeostasis and seal off the neural environment from circulating substances and cells. This physical barrier consists of a specialized endothelium that is sealed by tight and adherens junctions to restrict paracellular permeability (Zlokovic, 2008) . Specialized transporters such as the glucose transporter GLUT1 and the transferrin receptor CD71 control uptake of nutrients across the barrier, while pump and receptor mechanisms dispose of toxic and waste products, such as the P-glycoprotein drug efflux transporter and the scavenging receptor low-density lipoprotein receptor-related protein-1 (LRP-1). The endothelium is supported by a basement membrane and enwrapped by pericytes, astrocytic endfeet, and neuronal synapses, all together establishing the neurovascular unit.
Role of Astrocytes in BBB Formation
The barrier properties of the CNS endothelium are not genetically preprogrammed and isolated brain ECs in culture lose their BBB characteristics, raising the question of which neighboring cell type accounts for the induction of the barrier characteristics (Rocha and Adams, 2009) . Pericytes establish direct contact with ECs, while astrocytes lie abluminally, though their endfeet can make direct contact with ECs ( Figure 3) . Historically, astrocytes received most attention and were shown to induce BBB properties in non-CNS-derived endothelium in vivo. Coculture experiments support a role for astrocytes in restricting BBB permeability by secreting Ang1, TGFb, GDNF, and FGF2. By expressing SSeCK, a protein C kinase substrate with antiangiogenic activity, astrocytes induce BBB maturation via an Ang1-mediated increase in EC tight junctions.
Perivascular astrocytic foot processes are characterized by polarized distribution of intramembranous orthogonal arrays of particles (OAPs) (Wolburg et al., 2011) . These complexes contain the water channel aquaporin 4 (AQP4), the potassium channel Kir4.1, and a dystroglycan-dystrophin complex. OAP clustering relies on interactions with ECM proteins in the glial limiting membrane separating pericytes and astrocytes. AQP4 and Kir4.1 play a role in ion and water homeostasis at the glial-endothelial interface. The significance of OAPs remains, however, poorly understood. Some reports suggest an influence on BBB permeability, while others refute such effect (Wolburg et al., 2011) .
Role of Pericytes in BBB Formation
Pericytes seem to have more important roles in the establishment of the BBB than previously anticipated, in part because the BBB is formed in the embryo when pericytes are present but astrocytes have not arisen yet (Daneman et al., 2010) ( Figure 3 ). The development of astrocytes at later time points raises the question of whether these cells might control BBB function more importantly after birth. Using different hypomorph PDGFRb mutants with variable levels of residual pericyte coverage, pericytes were found to play a critical role in establishing a barrier function in vivo, with the microvascular permeability inversely correlating with pericyte coverage (Daneman et al., 2010) . Pericyte loss was associated with junctional abnormalities and increased transendothelial transport, without overt changes in BBB markers. Levels of Ang1, a pericyte-derived mediator of endothelial quiescence promoting the formation of interendothelial junctions, were decreased in pericyte-deficient mice (Daneman et al., 2010) , while expression of angiopoietin-2 (Ang2), an Ang1 antagonist, was enhanced.
Role of Neural Progenitors in BBB Formation
Neural progenitors also participate in establishing the BBB by secreting Wnt ligands that activate b-catenin signaling in ECs ( Figure 3 ). Genetic studies show that b-catenin signaling in ECs in vivo is required to induce and maintain BBB properties such as the expression of the glucose transporter Glut1 and the tight junction molecule claudin3 (Daneman et al., 2009; Liebner et al., 2008; Stenman et al., 2008) . Moreover, avb8 integrin-mediated adhesion of neural progenitors and their glial progeny to the neurovascular unit are required for morphogenesis of the forebrain vasculature. Indeed, deletion of avb8 in neural progenitors results in the formation of misshaped EC clusters and cerebral hemorrhage despite basement membrane formation and pericyte coverage (McCarty, 2009) .
Role of the Neurovascular Link in Development
More than five centuries ago, the Belgian anatomist Vesalius discovered that nerves and vessels track along each other to reach their target. The vascular and nervous system display intriguing parallelisms in their stereotyped architectural patterning and functional organization (Carmeliet and Tessier-Lavigne, 2005) . Explanations for this copatterning are that neurons and ECs respond to the same (classes of) molecular cues, or that they coregulate each other's migration. As the vascular system developed later in evolution than the nervous system, vessels are believed to have co-opted some of the genetic pathways for similar biological processes. Four classical axon guidance cue families (netrins, slits, ephrins, semaphorins) guide growth cones of axons and regulate navigation of endothelial tip cells via similar principles of repulsion and attraction, which we will illustrate here only with a few (recent) prototypic examples. Endothelial Cell Guidance by Neuronal Signals Endothelial tip cells extend filopodia that explore their surroundings for guidance cues. Neuropilin-1 (Nrp1) was discovered as a receptor for semaphorins in repulsive axon guidance but is also a coreceptor for VEGF and other angiogenic factors on ECs (Carmeliet and Tessier-Lavigne, 2005 ). Nrp1 null embryos succumb due to cardiovascular malformations because of an interrupted interaction with VEGF (Fantin et al., 2009; Rosenstein et al., 2010) . Nrp1 blockade is currently being evaluated as novel anti-angiogenic strategy for the treatment of cancer (Bagri et al., 2009) . Semaphorins, other ligands of Nrp1, usually inhibit angiogenesis, though some can also be stimulatory (Capparuccia and Tamagnone, 2009) . By activating Plexin-D1 directly, semaphorin 3E (Sema3E) controls vessel navigation via distinct mechanisms. In intersomitic vessels in zebrafish embryos, Sema3E, produced by perivascular cells, prevents ECs from erroneous navigation in unwanted territories, presumably by reorienting the cytoskeleton of the tip cell itself. By contrast, in postnatal mouse retinal vascularization, Sema3E produced by perivascular neurons activates Plexin-D1 on tip cells to coordinate vessel navigation by finetuning the precise balance of tip versus stalk cells, required for even growing vessel fronts and branching (Fukushima et al., 2011; Kim et al., 2011) . Molecularly, Sema3E/Plexin-D1 finetunes VEGF's activity in a negative feedback by suppressing Dll4 expression in tip cells.
Netrins can act as chemoattractants when activating the DCC and DSCAM receptor families, and as repellants when binding to the Unc5 receptor family (Unc5a-d). Consistent with a role of Netrin in vessel guidance, aberrant filopodia formation on tip cells and enhanced vessel branching were observed after deletion of Unc5b, while Netrin-1 overexpression inhibited vessel invasion (Adams and Eichmann, 2010) . Moreover, Netrin-4 inhibits EC growth via binding to neogenin and Unc5b (Lejmi et al., 2008) . However, others reported divergent effects of Netrin family members (Chan et al., 2010) . These seemingly contradictory reports may be possibly reconciled by findings that the angiogenic activity of Netrin-1 results from blocking apoptosis induced by its unbound Unc5b dependence receptor (Castets and Mehlen, 2010 ), but will require further study.
Slit glycoproteins act as repulsive axon guidance cues by activation of the Roundabout receptor family (Robo1-3) (Ypsilanti et al., 2010) . The endothelial-specific Robo4 promotes vascular integrity by suppressing VEGFR2 signaling (London et al., 2009) , but the responsible ligand of Robo4 remains debated since neither an interaction with Slit nor a vascular phenotype for Slit or Robo members has been demonstrated. Instead, Robo4 reduces VEGF responses via binding to Unc5b in ECs (Koch et al., 2011) .
Binding of ephrin ligands to Eph receptors induces bidirectional signal transduction in both the receptor cell (''forward signaling'') and ligand cell (''reverse signaling'') (Pitulescu and Adams, 2010) . Both events allow sorting and positioning of cells, determined by their expression of particular Ephs and ephrins. In the CNS, Eph-ephrin signaling mostly generates repulsive signals for navigating axons (Klein, 2009) . ECs use Eph-ephrin signaling to regulate their guidance and maturation. For instance, during coalescence of a primitive vascular plexus, repulsion of ephrin-B2 + arterial and EphB4 + venous ECs prevents intermingling and ensures segregation into separate venous and arterial territories (Swift and Weinstein, 2009) . Repulsive Eph-ephrin interactions also control the segregation of EphB4 + venous-fated ECs from ephrin-B2 + arterial-fated ECs in a common precursor vessel to establish the dorsal aorta and cardinal vein in zebrafish embryos (Herbert et al., 2009) . Moreover, ephrin-B2 reverse signaling regulates vessel guidance by controlling VEGFR internalization and tip cell behavior. ECs expressing a mutant ephrin-B2 are unable to internalize VEGFR2 and VEGFR3, thereby impairing VEGF signaling and filopodia formation (Sawamiphak et al., 2010; Wang et al., 2010b) . Neuron/Axon Guidance by Vascular Signals The neurovascular link is bidirectional and molecules originally discovered as angiogenic molecules also have roles in establishing the connectivity of the nervous system-they have been termed ''angioneurins'' (Zacchigna et al., 2008) . One of the best-known examples is VEGF, which regulates neuronal cell migration (Ruiz de Almodovar et al., 2009) , axon guidance (Erskine et al., 2011; Ruiz de Almodovar et al., 2011) , turning of leading processes of migrating cerebellar neurons , and dendritogenesis (Licht et al., 2010) . VEGF-D, another member of the VEGF family, controls the length and complexity of dendrites in hippocampal neurons and regulates memory formation (Mauceri et al., 2011) . Moreover, D. melanogaster and C. elegans lacking an elaborate vascular network express an ancestral VEGF variant that affects nervous development (Zacchigna et al., 2008) . Sema3E stimulates axon elongation via binding to a Plexin-D1/Nrp1 complex with subsequent VEGFR2 activation (Bellon et al., 2010) . Other ''angioneurins'' include members of the TGFb1, Shh, Wnts, BMPs, FGFs, and other families (Zacchigna et al., 2008 ).
An intriguing question is whether hypoxia, a proangiogenic stimulus, regulates CNS wiring. Initial support heretofore is provided by genetic studies in C. elegans. When challenged by low oxygen, this invertebrate mounts a protective organismal survival response by upregulating the Eph-receptor VAB-1, a repulsive guidance receptor in the CNS; the price to pay for the protection is that axon pathfinding is perturbed (Pocock and Hobert, 2008) . Hypoxia also activates circuits for processing sensory information, underscoring that oxygen levels influence CNS wiring (Pocock and Hobert, 2010) . Neurovascular Congruency Another example of the neurovascular link is the coalignment of vessels and nerves, with nerves guiding vessels tracking alongside nerves, and vice versa. For instance, neural crest cells (NCCs) give rise to autonomic nerves that innervate SMCs of peripheral resistance arteries (Ruhrberg and Schwarz, 2010) . These autonomic nerves regulate contractility and tissue perfusion. Resistance arteries attract their own innervation by secreting guidance cues for sympathetic neurons including VEGF, artemin, NT-3, and endothelin-3 (Ruiz de Almodovar et al., 2009) . Besides its role in establishing the autonomic innervation, VEGF remains necessary for the maintenance of this autonomic nervous network in adulthood. Reduced production of VEGF by SMCs in VEGF-hypomorph VEGF v/v mice renders periarterial autonomic nerves dysfunctional (Storkebaum et al., 2010) . Pial arteries also possess (para)sympathetic and sensorymotor perivascular nerves that originate from peripheral ganglia, referred to as ''extrinsic'' innervation, but little is known about the molecules regulating the development and maintenance of these nerves. In the other direction, axons guide vessels to cotrack along them. For instance, certain embryonic arteries are associated with sensory nerves and follow axonal patterning, though the precise molecular nature of these vascular guidance signals remains to be determined (Zacchigna et al., 2008) .
Endothelial and Neural Cell Fate Decisions
Some signals commonly determine cell fate decisions in the nervous and vascular system. For instance, VEGF and Notch regulate neurogenic commitment of neural stem cells (NSCs) (Pierfelice et al., 2011) as well as endothelial arterial/venous cell fate specification (Swift and Weinstein, 2009) . Genetic studies in zebrafish show that VEGF upregulates Notch expression to drive arterial EC differentiation during development. In the PNS, VEGF produced by Schwann cells determines arterial specification of ECs in cotracking vessels (Ruiz de Almodovar et al., 2009) . Notch determines arterial development, as illustrated by the loss of arterial identity of SMCs resulting in a venous-like appearance of cerebral arteries (thinner media, dilated lumen) upon SMC-selective disruption of Notch (Gridley, 2010) . In these mice, the anterior communicating arteries in the circle of Willis fail to anastomose, impairing collateral blood flow and rendering them vulnerable to cerebral artery occlusion. The Neurovascular Niche While neural cells stimulate vessel growth by releasing VEGF and other angiogenic factors, vessels also crosstalk to neural cells, not only by functioning as conduits for oxygen and nutrient supply, but also by releasing angiocrine signals to promote neuronal development (Butler et al., 2010) . This seems to be particularly the case in the neurogenic niche, where periventricular vessels develop coincidently with the onset of cortical neurogenesis (Vasudevan et al., 2008) . Consistent with reports that hypoxia promotes stemness (Mohyeldin et al., 2010) , NSCs reside in a hypoxic neurogenic niche in the ventricular zone at a distance from the vascular supply (Mazumdar et al., 2010) (Figure 4A ). Basal progenitors, already committed to the neuronal , cells with stem cell properties-radial glia and adult NSCs, respectivelydivide at a distance from the blood vessels. In contrast, their more differentiated progeny-basal progenitors in development (A) and transit amplifying progenitors (TAPs) in the adult (B)-are attracted by and migrate to the blood vessels of the periventricular vascular plexus to divide in the perivascular niche. During development, these divisions generate mainly cortical neurons that leave the vascular niche to migrate to the cortex (A); similarly, TAPs in the adult SEZ give rise to neuroblasts that migrate to the olfactory bulb (B). (C) Neuroblasts use blood vessels as a cellular substrate for this migration. Blood vessels guide p75-expressing neuroblasts by releasing BDNF, while neuroblasts regulate the local BDNF concentration by releasing GABA to induce BDNF uptake via TrkB by local astrocytes.
lineage, leave the avascular part and migrate toward the vascular plexus in the adjacent subventricular zone (Johansson et al., 2010) . Intriguingly, vessels invade the subventricular germinal zone when the first basal progenitors arise (Vasudevan et al., 2008) . These progenitors become aligned with vessels and undergo neurogenic divisions in close vicinity of vessel branch points. In contrast, divisions that generate NSCs or basal progenitors to expand the pool of stem and progenitor cells take place in the less vascularized part of the ventricular zone (Johansson et al., 2010) . These spatial and temporal patterns suggest a role for vessels in the neurogenic niche to coordinate neurogenesis, but how oxygen and/or vessel-derived signals fine-tune this process and which angiocrine molecular signals are involved requires further study. In line, cultured ECs release signals that stimulate proliferation of neural precursors and bias their differentiation to a neuronal fate (Shen et al., 2004) .
Role of the Neurovascular Crosstalk in Disease
Throughout adulthood, communication between the nervous and vascular system remains required for maintenance of the BBB, for providing endothelial-derived neurotrophic functions and promoting neuroregeneration. Defects in this crosstalk can result in neurological disorders.
Dysregulation of Cerebral Vascular Perfusion
While vessels feed neural cells with nutrients and oxygen, neural cells provide feedback to vessels regarding their metabolic needs. The regulation of brain perfusion takes place at various levels: large arteries receive innervation from central autonomic nerves, while SMCs in smaller arterioles respond to signals from astrocytes and possibly neurons, allowing regional dynamic adjustments of blood flow in response to changing neuronal activity (functional hyperemia) (Attwell et al., 2010) . Pericytes can alter the capillary diameter but whether they contribute to functional hyperemia remains debated (Attwell et al., 2010) . Findings that the vasoreactivity of CNS vessels with subnormal coverage of pericytes is perturbed suggest at first sight that pericytes regulate functional hyperemia (Bell et al., 2010) , but possible SMC defects were not excluded and a recent study refutes a role for pericytes in physiological conditions (Ferná ndez-Klett et al., 2010) . Overall, the precise role of pericytes in cerebral blood flow (CBF) regulation requires further study. Deficient CBF control occurs in various neurological diseases and can contribute to neuronal damage via neurovascular uncoupling and hypoperfusion (Iadecola, 2004) . Oxidative stress in ECs seems to be a common cause of perturbed functional hyperemia and cerebrovascular autoregulation in Alzheimer's disease (AD), arterial hypertension, and diabetes mellitus by interfering with endothelial production of vasodilatory substances. In AD for instance, amyloid-b (Ab) triggers endothelial production of oxygen radicals by the NADPH oxidase via activation of the Ab receptor CD36 (Iadecola, 2010; Park et al., 2011) . Besides NADPH oxidase as a major source of oxygen radical formation, mitochondria in ECs can also contribute. Indeed, mitochondria are more abundant in ECs of the brain than of other peripheral organs and may also generate oxidative stress. For instance, in MELAS, a mitochondrial disease characterized by encephalomyopathy, EC oxidative damage due to dysfunctional mitochondria compromises vasodilatation, explaining the predisposition for stroke-like episodes (Koga et al., 2006) . Vascular mural cell abnormalities can also contribute to perfusion deficits. For instance, in AD, SMCs upregulate the transcription factors SRF and myocardin (MyoCD) that increase arterial contractility and thus could reduce CBF (Chow et al., 2007) . Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is another example of cerebrovascular dysregulation long believed to be due to abnormal SMC structure and function (Joutel, 2011) . CADASIL is an inheritable small vessel disease caused by mutations in Notch3 and characterized by progressive subcortical ischemic injury. Both in CADASIL patients and mouse models, disturbed functional hyperemia and cerebrovascular autoregulation occur as one of the earliest events, suggesting a disease-initiating role. However, contrary to common belief in the past that CADASIL is a SMC-centric disease only, impaired CBF autoregulation in combination with capillary rarefication rather than SMC degeneration and vascular sclerosis seem to be of primary causal importance (Joutel, 2011) .
In pathological conditions, pericyte dysfunction or deficiency can impair cerebrovascular reactivity. After stroke, local CBF is decreased for protracted periods, even after reperfusion of the occluded vessel; pericyte contraction in response to reactive oxygen species (ROS) has been involved in this no-reflow phenomenon (Yemisci et al., 2009) , though other mechanisms also contribute. It is therefore tempting to speculate that these mural cells might have a more important role in pathological than physiological conditions. Breakdown of the BBB BBB breakdown has been recognized in various neurological diseases (Zlokovic, 2008) . In stroke, meningitis, and trauma, BBB leakiness is a consequence of the insult, but evidence indicates that primary BBB dysfunction can also cause neurologic diseases via several mechanisms: leakage of neurotoxic proteins (immunoglobulins, thrombin, fibrin) resulting in ROS production and inflammation, accumulation of waste products (Ab) due to defective disposal, deficient nutrient transport, insufficient production of neurotrophic factors, entry of inflammatory cells leading to immune responses and possibly axonal demyelination, and perivascular edema compromising perfusion.
At the molecular level, dysregulated PDGFRb signaling is one of the few pathways, discovered so far to cause functional BBB maintenance defects evoking secondary neurological dysfunction. Indeed, disruption of this EC/pericyte molecular communication causes progressive pericyte loss and coincident BBB hyperpermeability after birth (Armulik et al., 2010; Bell et al., 2010) . However, as these mutant lines lack pericytes already in development, it is unclear to what extent loss of pericytes in adulthood can contribute to BBB leakage; inducible gene inactivation studies in pericytes will be required to answer this question. Structural junctional abnormalities, increased transendothelial transport and basal lamina deficits, thought to impair anchoring of astrocytic endfeet to the vessel wall, are believed to cause the BBB dysfunction in pericyte-deficient mice (Armulik et al., 2010; Bell et al., 2010) . The (pre)clinical importance of BBB defects is reflected by findings that these mice, displaying an age-dependent reduction in CBF and BBB breakdown, develop a neurodegenerative-like phenotype with progressive neuronal loss along with cognitive deficits (Bell et al., 2010) (Figure 5 ). These insights illustrate that pathological BBB leakiness not only is the result of neuronal insults but can also initiate neurodegeneration, arguing for a causative role of vascular deficits in neurodegeneration.
There is also initial evidence for possible causative role of a dysfunctional BBB in other neurodegenerative diseases. For instance, in an amyotrophic lateral sclerosis (ALS) mouse model, leakiness of the blood-spinal cord barrier owing to reduced expression of tight junctions and Glut1 precedes the onset of motoneuron degeneration (Garbuzova-Davis et al., 2011). However, deletion of mutant SOD in ECs in an ALS mouse model overexpressing mutant SOD attenuates BBB leakiness without improving survival (Zhong et al., 2009) (Figure 6 ). The relevance of BBB abnormalities in ALS thus requires further elucidation.
AD represents the prototypic example of a dysfunctional neurovascular unit. The main culprits are Ab peptides, formed after cleavage of amyloid precursor protein (APP) by BACE (b-site AAP-cleaving enzyme) and subsequently g-secretase. While mutations of these candidate genes result in increased Ab production in rare familial cases, the more common lateonset sporadic form is caused by impaired Ab clearance (Mawuenyega et al., 2010) . Besides clearance via microglia and macrophages, Ab is also transported across the BBB by LRP-1 or passively drained along perivascular spaces (Bell and Zlokovic, 2009 )-both mechanisms are impaired in AD. As a result of atherosclerotic or small vessel disease (conditions associated with AD), the vessel wall is stiffened, and pulsatile flow and perivascular fluid movement are reduced, impeding Ab drainage. Ab clearance is further compromised due to the vasoconstriction by hypercontractile SMCs and to the reduced endothelial LRP-1 expression, both resulting from overexpression of MyoCD and SRF Chow et al., 2007) . Since short-term administration of Ab 1-40 but not of the plaqueforming Ab 1-42 is known to induce oxidative damage of cerebral vessels and impair CBF (Iadecola, 2010) , the resultant elevated Ab levels will in turn cause vascular dysfunction (Figure 7) .
Eventually, Ab accumulation in the vascular wall, a condition referred to as cerebral amyloid angiopathy (CAA), destroys microvascular structure and function, leading to loss of the BBB integrity along with an inflammatory response, compromising neuronal viability. Since exposure of cultured neuronal cell lines to hypoxia or of mice to severe ambient hypoxia is capable of upregulating the expression of APP cleaving enzymes and transcription factors MyoCD and SRF, vascular insufficiency might further enhance amyloid production and compromise amyloid clearance, causing a vicious circle whereby Ab accumulation aggravates vascular deficits and vice versa. However, whether sufficient hypoxia is present in early AD to upregulate these factors requires further study. The cerebral amyloid accumulation in mouse models of arterial hypertension and CADASIL provide additional evidence for a causal role of vascular defects in AD pathology and illustrates how AD and cerebrovascular disease share common risk factors. Hypoperfusion Due to Insufficient Angiogenic Signaling Cerebral hypoperfusion resulting in neurological symptoms can be caused by inadequate patency of supply vessels, as occurs in cerebral angiopathies of large supply arteries when affected by atherosclerosis or in small vessel disease in the context of hypertension, diabetes mellitus, or CADASIL (Moskowitz et al., 2010) . Brain hypoperfusion due to vascular abnormalities can also occur in neurodegenerative disorders such as AD, ALS, and Parkinson's disease (PD) (Zlokovic, 2008) . However, the causative nature of these vascular alterations has been debated in the past: do vascular defects cause neurodegeneration and/or accelerate disease progression, or are they a consequence of neuronal loss and cerebral hypometabolism.
At least some studies have been instrumental in revealing a causal link. First, VEGF v/v mice with reduced VEGF levels suffer adult-onset motoneuron degeneration, reminiscent of ALS (Oosthuyse et al., 2001; Ruiz de Almodovar et al., 2009) . The CNS of VEGF v/v mice is hypoperfused, likely due to a lack of EC survival signaling (Lee et al., 2007) . It remains, however, unresolved whether and how hypoperfusion occurs prior to neuronal loss, and what precisely the relative role is of hypoperfusion versus reduced VEGF-mediated neuroprotection ( Figure 6 ). Second, a reduction in brain perfusion and vessel density in PDGFRb mutant mice or in mice lacking Meox2 (Mesenchyme Homeobox 2, a transcription factor regulating vascular differentiation) results in neuronal loss and cognitive impairment (Bell et al., 2010) (Figure 5 VEGF levels are reduced in ALS patients and rodent models leading to endothelial dysfunction, hypoperfusion, and BBB breakdown including loss of endothelial tight junctions and the GLUT1 transporter that is responsible for glucose transport across the BBB. Despite the fact that VEGF administration delays the disease in rodents, it is currently not known whether and how vascular dysfunction contributes ALS.
to onset of neuronal death (Garbuzova-Davis et al., 2011; Iadecola, 2010) , implying that vascular abnormalities actively contribute to neurodegeneration.
Whether hypoperfusion in neurodegeneration is due to insufficient angiogenic signaling and if so, which molecules are at play remains largely outstanding. In AD, besides perturbing ECs structurally and functionally by causing oxidative stress, Ab squelches VEGF, inhibits VEGF binding to its receptor, suppresses EC mitogenic and survival responses to VEGF and FGF2, and induces EC autophagy, senescence, and apoptosis (Donnini et al., 2010; Patel et al., 2010) . AD patients have reduced levels of endothelial progenitor cells, implicated in repairing damaged endothelial lining. Subnormal VEGF levels in AD patients might aggravate vascular insufficiency, but elevated VEGF levels have been also documented, presumably in an effort to compensate for impaired VEGFR2 signaling (Ruiz de Almodovar et al., 2009) . Not only ECs are targeted in AD, since Ab deposits have been also detected around degenerating pericytes and SMCs, but to what extent dysfunctional mural cells causally contribute to AD's pathogenesis remains outstanding. Overall, despite upregulation of angiogenic molecules, angiogenesis is nonproductive in AD and cannot repair the damaged CNS vasculature.
Human genetic studies provide only limited support for a link between angiogenic factors and AD so far (Ruiz de Almodovar et al., 2009) . In ALS, VEGF gene haplotypes that lower VEGF levels are associated with an increased risk in genetically homogeneous populations, while a meta-analysis of over 7,000 individuals documented an increased risk of ''at-risk'' VEGF gene variations in males . VEGF levels in the cerebrospinal fluid of ALS patients are decreased, which could relate to impaired VEGF mRNA translation due to mutant SOD1. ALS can also result from mutations in angiogenin, another putative angiogenic factor (Li and Hu, 2010) .
Cerebrovascular Malformations
In the healthy adult, cerebral vessels are quiescent and constitute a guardian for the CNS microenvironment. However, abnormal molecular regulation of vessel quiescence can lead to abnormal vessel growth, all or not accompanied with leakiness. In many cases, these lesions occur sporadically and their underlying molecular basis remains elusive. We will therefore highlight two prototypic monogenic hereditary cerebrovascular diseases characterized by vascular malformations for which novel molecular insight have been obtained, but Table 1 lists a more complete overview of the known monogenic cerebrovascular anomalies.
Human hereditary teleangiectasia (HHT), also known as Rendu-Osler-Weber disease, is an autosomal-dominant inherited vascular dysplasia causing arteriovenous malformations (AVMs) and teleangiectasias in the brain and other organs (Shovlin, 2010) . Typical for AVMs are the presence of arteriovenous shunts without intervening capillary bed, and the presence of dilated tortuous veins that, despite perfusion at arterial pressure, fail to become ''arterialized'' but maintain walls with venous molecular signature and appearance. Like CCMs (see below), they can cause neurological symptoms of varying severity and expressivity including headache, focal neurological deficits, seizures, and hemorrhagic stroke. Autosomal dominant mutations have been identified in three genes-i.e., ENG encoding endoglin, ACVRL1 encoding activin receptor-like kinase 1 (ALK1), and SMAD4 encoding SMAD4, all functioning in TGFb signaling (Pardali et al., 2010) . The TGFb pathway controls vessel wall stability and balances the angiogenic response during vascular remodeling.
How haploinsufficient TGFb signaling gives rise to vascular malformations is incompletely understood, though reduced mural cell coverage together with increased EC growth may cause vessel dilatation without accompanying maturation, resulting in deregulated vessel remodeling and formation of fast-flow arteriovenous shunts (Shovlin, 2010) . A second hit, i.e., injury, induction of vessel growth, inflammation or hemodynamic overload, or other stimuli, is likely required to initiate focally a deregulated angiogenic response leading to AVM formation. TGFb intersects with Notch signaling in establishing mature cerebrovascular circuits, since an interaction between SMAD4 and RBP-J, a downstream target of Notch, is necessary for endothelial expression of N-cadherin to ensure proper pericyte coverage and cerebrovascular integrity . Besides symptomatic interventional procedures, initial attempts are being made to explore molecular targeted therapy (pre)clinically, including the use of the anti-VEGF antibody bevacizumab to inhibit the raised VEGF levels that cause overgrowth of immature vessel anomalies, and thalidomide to restore vessel maturation by upregulating PDGF-B (Lebrin et al., 2010) .
Cerebrovascular cavernous malformations (CCMs) are characterized by collections of dilated, leaky capillary caverns vulnerable to rupture and bleeding. Apart from other theories, one model postulates that CCMs arise by venous dysplasia, leading to venous hypertension and secondary hypoxia, which then upregulates angiogenic factors and induces EC growth. Since these lesions consist largely of ECs alone without support of pericytes or other neural cells, deregulated EC-autonomous mechanisms were suspected disease candidates. Indeed, in inherited cases, haploinsufficient mutations of three CCM genes, encoding KRIT1 (CCM1), malcaverin (CCM2), or PDCD10 (CCM3), are linked with this condition (Leblanc et al., 2009b; London et al., 2009) . EC-selective loss-of-function studies confirmed the endothelial cell-autonomous role of the CCM genes, while global inducible CCM gene inactivation studies generated disease models that reliably reflect the human condition (Cunningham et al., 2011) . A second hit theory, in which the residual allele is lost via somatic mutation in single ECs in subjects with a monoallelic germline mutation, might explain their focal nature, though genetic mutations in other pathway members or environmental pro-angiogenic conditions cannot be excluded as second hit either.
Functional studies have only begun to unravel the complex molecular pathology. CCMs are intracellular proteins that act in a trimolecular complex as scaffolds linking molecules on the cell surface (integrins, VE-cadherin, orphan receptor HEG1) to downstream intracellular signaling cascades in order to regulate cytoskeletal actin dynamics, vessel branching, lumen generation, barrier formation, endothelial lining repair, and other morphogenetic processes (Faurobert and Albiges-Rizo, 2010) . The uncontrolled angiogenic signaling in CCM may be also related to inhibition of Dll4/Notch signaling (Wü stehube et al., 2010) . Like Dll4 blockade, loss of CCM1 results in hyperproliferative vascular lesions by activating b-catenin driven gene transcription (Glading and Ginsberg, 2010; Yan et al., 2010) . However, the precise pathophysiology of CCM remains incompletely understood, as CCM3 stabilizes VEGFR2 signaling, a molecular pathway promoting tip cell formation . Based on insights implicating RhoA in the CCM pathway, inhibitors of Ras signaling are being evaluated as possible therapeutics (Borikova et al., 2010) .
Besides monogenic cases, various other diseases characterized by vascular abnormalities occur sporadically and are likely polygenic in nature. Elucidating the genetic basis of cerebrovascular malformations promises not only to understand better how CNS vessels form but also to develop much needed molecular targeted therapies for these conditions. An example is the successful treatment of ocular neovascularization with a blocking anti-VEGF antibody in patients suffering the wet form of age related macular degeneration, a prime cause of blindness in the elderly (Campa and Harding, 2011) .
Insufficient Neurotrophic Signaling by Endothelial or Angiogenic Factors
Angioneurins not only direct neurovascular development, but are also indispensable signal molecules governing neuroprotection and -regeneration in adulthood. Genetic evidence that insufficient neurotrophic signaling by angiogenic factors can promote neurodegeneration stems from the ALS field, where reduced VEGF levels in VEGF v/v mice and in humans are associated with motoneuron degeneration (Ruiz de Almodovar et al., 2009) . Besides a role for hypoperfusion, deficient neuroprotective signaling is relevant since neuronal overexpression of VEGFR2 delays disease progression in ALS mouse models. Two other examples of insufficient neuroprotective signaling include Kennedy's disease where the mutated expanded androgen receptor interferes with VEGF transcription and, second, ALS caused by mutations in angiogenin, both resulting in impaired motoneuron survival (Ruiz de Almodovar et al., 2009; Sebastià et al., 2009) . Disturbances in axonal outgrowth and synaptic plasticity represent additional mechanisms. Indeed, in ALS patients and animal models, there is evidence for an imbalance of repulsive over attractive axon guidance cues (Schmidt et al., 2009) , while motoneurons from VEGF v/v mice express lower levels of genes involved in axonogenesis (Brockington et al., 2010) . Additionally, inappropriate proteosomal degradation of the axon guidance molecule EphB2 contributes to AD pathogenesis by perturbing NMDA-receptor dependent long-term potentiation (Cissé et al., 2011) .
Is the Neurovascular Stem Cell Niche Involved?
ECs not only build channels to conduct oxygen and nutrients, but also provide neurotrophic signals and create a niche facilitating neuronal maintenance and repair, independently of perfusion. Specialized niches in the subependymal zone (SEZ) of the lateral ventricles and in the subgranular zone (SGZ) of the hippocampal dentate gyrus harbor a population of adult NSCs that generate new neurons throughout life (Butler et al., 2010; Goldberg and Hirschi, 2009) (Figure 4B ). In both niches, cycling neural progenitors are found in close proximity to vessels in the neurovascular stem cell niche (Shen et al., 2008; Tavazoie et al., 2008) ; however, the nature of the SEZ and SGZ niches is different.
In the adult SEZ, the niche is derived from the periventricular vascular plexus and is already present in development. ECs in this niche are quiescent and the BBB allows passage of low-molecular-weight circulating substances (Tavazoie et al., 2008) . Slowly dividing NSCs with long-term self-renewal potential are not located in close vicinity of periventricular vessels, but contact them via endfeet of their long basal processes (Beckervordersandforth et al., 2010; Shen et al., 2008) . These NSCs express VEGFR3, required for NSC maintenance and olfactory bulb neurogenesis (Calvo et al., 2011) . Once activated to initiate division, NSCs and the continuously proliferating transit-amplifying progenitors (TAPs) become attracted to periventricular vessels via SDF1-CXCR4 signaling (Kokovay et al., 2010; Tavazoie et al., 2008) . The perivascular ECM in the SEZ niche functions as a deposit of growth factors to support neural precursor proliferation. Thus, signals derived from SEZ vessels foster proliferation of neural precursors, while long-term self-renewing stem cells are located in the more hypoxic niche to maintain quiescence (Mohyeldin et al., 2010) .
The development of the SGZ niche occurs primarily postnatally. SGZ vessels have an intact BBB and restrict access of systemic factors to NSCs. Proliferation of NSCs and neural progenitors is tightly coupled to SGZ angiogenesis, and proliferating ECs and neural precursors colocalize in the niche (Van der Borght et al., 2009) . Stimuli like exercise increase hippocampal neurogenesis and angiogenesis by upregulating VEGF in this niche. However, besides direct neurogenic and angiogenic effects of VEGF, expansion of the vascular niche alone can also contribute, since persistent vascular expansion in the SGZ induced by transient overexpression of VEGF increases neurogenesis even after cessation of VEGF expression (Licht et al., 2011) .
Vessels provide a substrate for guidance of migrating neuroblasts in adult neurogenesis and facilitate long-range migration of neuroblasts out of the SEZ toward the olfactory bulb (OB) along the rostral migratory stream (RMS) ( Figure 4C ) (Saghatelyan, 2009) . RMS vessels are aligned parallel to the route of neuroblast migration, and nearly all migrating cells are attached to vessels (Snapyan et al., 2009) . ECs attract the neuroblasts by releasing BDNF; once attracted, neuroblasts release GABA, which triggers nearby astrocytes to take up BDNF, thereby ensuring navigation along RMS vessels. VEGF also regulates neuroblast migration along the RMS (Wittko et al., 2009) . In acute brain insults, hypoxia triggers a neurovascular response that results in increased angiogenic and neurogenic activity at the border of the lesion. This adaptive response can last for months and is associated with functional recovery (Jin et al., 2010) . This regenerative response relies on reciprocal neurovascular interactions. Indeed, after stroke, neuroblasts deviate from the RMS and are attracted to the growing vasculature by SDF-1a and Ang1 in the peri-infarct cortex (penumbra), where they start neurogenesis (Saghatelyan, 2009) . Vessels also serve as substrate for migrating neural precursors into infarcted regions (Kojima et al., 2010) . Conversely, neural progenitors from the ischemic SVZ promote angiogenesis (Teng et al., 2008) . Disruption of the interaction between NSCs and vessels in the niche by cranial irradiation prevents neurogenesis (Goldberg and Hirschi, 2009) . Through plastic differentiation, pericytes can also contribute to glial scar formation after spinal cord injury (Gö ritz et al., 2011).
NSCs can give rise to glioblastoma (GBM) and GBM stem cells are also located in vascular niches, which they create by secreting VEGF (Gilbertson and Rich, 2007) . However, GBM stem cells can also give rise to tumor-derived endothelium by differentiation to ECs (Ricci-Vitiani et al., 2010; Wang et al., 2010a) . In the niche, vessels contribute to GBM stem cell maintenance by secretion of eNOS to activate Notch signaling, but ECs also secrete unidentified factors to maintain and expand GBM stem cells (Galan-Moya et al., 2011; Gilbertson and Rich, 2007) . Ablation of the vasculature decreases stem cell numbers in GBM and sensitizes the normally protected stem cells to irradiation damage (Hovinga et al., 2010) .
Therapeutic Perspectives for Neurovascular Medicine
From the above, it is evident that angiogenesis offers a range of therapeutic opportunities. Given the scope of the review, we will outline, as prototypic example, one emerging neurovascular therapeutic approach, which has recently progressed to clinical testing. * Non-Ab forms will not be discussed here. GOM: granular osmiophilic material; CARASIL: cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy; RVLC: retinal vasculopathy with cerebral leukodystrophy; Col4A1: collagen type 4, A1 isoform; HANAC: hereditary angiopathy with nephropathy, aneurysms, and muscle cramps; porencephaly: cerebral cyst, remnant of destructive lesion; HHT: hereditary hemorrhagic telangiectasia; CCM: cerebrovascular cavernous malformation; MELAS: mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke; AVM: arteriovenous malformation; AVF: arteriovenous fistulae.
The clearest example of a therapeutic candidate for neurodegeneration is VEGF. Based on the aforementioned insights, VEGF therapy was explored. Both VEGF gene transfer in motoneurons as well as intracerebroventricular (ICV) VEGF protein delivery prolonged the survival of ALS rodent models (Ruiz de Almodovar et al., 2009) . The therapeutic effect of VEGF in ALS relies on a neuroprotective effect, in addition to a possible effect on microvascular maintenance or perfusion (Ruiz de Almodovar et al., 2009) . The benefit of ICV delivery of VEGF protein for ALS patients is currently being clinically evaluated in phase I/II trials. Deficiency of another VEGF family member, e.g., VEGF-B, does not cause ALS by itself, but aggravates motor neuron degeneration in ALS mouse models (Poesen et al., 2008) . ICV delivery of recombinant VEGF-B also reduces motor neuron death and prolongs survival in an ALS model, without causing any observable adverse effects on vessel growth or permeability.
Conclusion and Outstanding Questions
The ''neurocentric'' viewpoint about neurodegeneration and several other neurological disorders has prevailed for a long time. However, in the last two decades, the brain vasculature has increasingly entered the center stage as a key player that actively influences and directs brain development, homeostasis, and disease. Despite tremendous progress in understanding the functional properties of brain vessels in recent years, numerous questions remain unanswered. We will highlight here only a few examples. For instance, emerging evidence suggests that vessel growth in the brain relies in part on specific, perhaps even unique proangiogenic signals. Identifying their molecular nature offers great promise to understand neurovascular disorders and to develop novel neurovascular medicine. Second, the role of pericytes has turned out to be more important than previously recognized. Do pericyte abnormalities causally contribute to neurodegeneration and other types of neurological disorders, and can they be therapeutically targeted? Finally, the brain vasculature is now considered to be a major contributor of the neurogenic stem cell niche. Can this process be exploited for brain repair? Finding an answer to these and other questions promises to be a scientifically exciting journey with great translational potential.
